Article ID Journal Published Year Pages File Type
5583916 Seminars in Arthritis and Rheumatism 2017 5 Pages PDF
Abstract
Tocilizumab led to statistically significant improvement in all patient- and physician-reported measures of disease activity evaluated in this cohort of patient with RA. The response to tocilizumab did not differ by CCP status.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Anesthesiology and Pain Medicine
Preview
Tocilizumab treatment leads to improvement in disease activity regardless of CCP status in rheumatoid arthritis
Authors
, , , , ,